Get started

Bottomedchart

$AGHI could Move Up more than +240pct! Find Out why...===================== AGHI (Agora Holdings Inc.) Alert Price: $0.0862 Float: 29.48M Chart Analysis Company Website | Recent News ======================== Members, It's time to add a little more to this week's already impressive +59% realistic gains total!. We ask that you please turn your immediate attention to AGHI (Agora Holdings Inc.). We've had our eye on this highly diversified entertainment and media enterprise company for quite some time now, and it appears to be back in the buy-zone AGHI's chart has been in a bit of a downtrend the past few days, but we feel confident that the bottom is finally in. AGHI is looking like a picture perfect bottom'd chart bounce opportunity! Today, AGHI closed under 10-cents for just the third time this year! This could be the perfect entry point for traders looking to cash in on what could be AGHI's next triple-digit bullish reversal. The last time AGHI was trading at these levels, the stock reversed hard from $0.08 all the way to a high of of $0.30. If AGHI were to make a run back to $0.30 from today's alert price, traders would be able secure gains of up to +248%! You will also be happy to know, that AGHI has signed some impressive contracts over the past few week's, which has us bullish heading into Q2 AGHI Subsidiary, eSilkroad Network Limited, Enters Into Contract With Sannacode to Complete Programming on Its eSilknet Platform AGHI Subsidiary, eSilkroad Network Limited, Enters Into Formal Term Sheet With Tianjin Eastraise Business Technology Co., Ltd Securing Its First Strategic Partner in Mainland China At just $0.0862 per share, AGHI is trading at the lower-end of its 52-week price channel, and well off its 52-week high of $0.35. All you have to do is pull up AGHI's 6-month chart, to realize that this is the smart time to start building a position. AGHI has broken out for big gains from these levels time and time again. We have a feeling that AGHI's next big run-up is on the way, and we want everyone on board. That being said, we ask that all members read our full profile, start their research now, and consider grabbing up a position in AGHI tomorrow morning at 9:30AM EST! About Agora Holdings Inc. Agora Holdings Inc., together with its subsidiary Geegle Media and affiliates, is presently an entertainment and media enterprise. Agora Holdings Inc. brings together media and technology, driving innovation to enhance online entertainment in five business segments: media networks, TV, studio entertainment, consumer products and interactive media. Agora is seeking to expand its portfolio to include dynamic and interactive web-based networking platforms for global implementation. Divisions: Esilkroad Network Limited Esilkroad Network Limited and its subsidiary, eSilkroad of Ukraine, is a conceptual B2B platform that intends to make the interaction between businesses and non-profit organizations throughout the world faster, more effective, and less costly. eSilknet, the web-based platform under development by eSilkroad Network Limited will allow users to search for and communicate with business partners, search for and post proposals for investment and opportunity in developing projects globally, place advertisements for products and services, communicate securely on trade and project development and attract professional services for specific project-based needs. The concept of eSilknet is in line with the original concept of the “silkroad”, facilitating trade and commerce between countries, only a global scale. eSilkroad Network is currently negotiating the acquisition of complementary platform, “eSilktrade” which has been under development privately in Shanghai for several years. eSilkroad Network believes the combined expertise of its Ukraine based eSilkroad development team and the existing team at eSilktrade can integrate the live trade platform into its B2B site further enhancing value for its users. www.esilknet.com Software Development GEEGLE MEDIA Geegle Media’s project management is a value-driven approach that allows the company to deliver high-priority, high-quality work and look like rock stars to their stakeholders. Its nothing like the plodding, costly and error-prone approach to project management, which has delivered inconsistent results for years. Software projects change constantly. When customers are expected to finalize requirements before they can test-drive the prototypes, overhead and long delays often cripple the project. Geegle Media Management is about embracing change, even late in the development stage. It’s about delivering the features with the greatest business value first, and having the real-time information to tightly manage cost, time and scope. Geegle Media Project Management reduces complexity by breaking down the many-months-long cycle of building requirements for the whole project, building the entire product and then testing to find hundreds of product flaws. Instead small, usable segments of the software product are specified, developed and tested in manageable, two- to four-week cycles. Social Media/Marketing FLEET Takes Your social media campaigns to the next level! Frame gives You full control over Your social media campaigns Login using Facebook Login using Twitter Login using Instagram Manage all of Your social media channels in one place Schedule your posts for the right time Prepare your posts and prepare their share in the future. Save time and efforts. Publish posts on all social accounts you need. Generate professional infographic reports Use their analytic tools to generate professional presentations for social media performance in special designed templates Follow your best friends more intensive Follow what your social media friends upload and choose what posts to see Recent Developments Agora Holdings Inc. Subsidiary, eSilkroad Network Limited, Enters Into Contract With Sannacode to Complete Programming on Its eSilknet Platform On Tuesday, the Company announced that its controlled subsidiary, eSilkroad Network Limited (“ESR”) of Hong Kong, has completed prototype testing and focus groups during January and early February 2019, whereby over 300 corporations were exposed to our landing page prototypes. With testing complete, ESR has retained Sannacode (sannacode.com) to conclude programming of our final platform. Sannacode is a multi-disciplinary company that specializes in web design and development. Sannacode designs, develops, tests and maintains digital products ranging from web, mobile, games and wearable technologies. Headquartered in Kiev, Sannacode works with companies in every continent around the world. Their management team reflects the talent and focus to bring clarity to corporate visions including creating customized solutions for ESR. The Sannacode team offers a combined 30 years of experience in design, development and testing. ESR President Oleg Sytnyk commented, “We are extremely excited to be working with Sannacode to complete the final phase of our platform development. Their firm is uniquely qualified to deliver the high level of functionality and design we wish to present in our final commercial site.” Market Outlook The social media market has been hot for the past few years. Companies have realized social media could be one of the main drivers of growth. However, with the Facebook scandal, it’s opened the market up for new competitors to join in on the action. According to Research and Markets, B2B e-commerce sales are forecast to be over two times higher than global online retail sales. That said, there is immense growth potential in the market. A report from Forrester Research in 2017 estimated business-to-business (B2B) ecommerce transactions would reach $1.2 trillion by 2021. Frost & Sullivan has even loftier expectations with B2B ecommerce hitting $6.6 trillion by 2020. Over 400,000 organizations are already shopping on Amazon Business with B2B. Technical Analysis As we enthusiastically stated above, AGHI has a well recorded history of breaking out big from these exact levels.. The last time AGHI was trading at these levels, the stock reversed hard from $0.08, all the way to a high of of $0.30. If AGHI were to make a run back to $0.30 from today's alert price, traders would be able secure gains of up to +248%! We've done our very own chart analysis, and see the potential for a move of +60%-100%! But remember, AGHI's trading history has shown us multi-day rallies of much more than that. All you have to do is pull up AGHI's 6-month chart, to realize that this is the smart time to start building a position. AGHI has broken out for big gains from these levels time and time again. We have a feeling that AGHI's next big run-up is on the way, and we want everyone on board. As such, we are urging all members to start their research now, and consider grabbing up a position in AGHI tomorrow morning at 9:30AM EST! (*Remember to use a basic Stop-Loss Order or more advanced Stop-limit Order to protect your gains, as well as limit possible losses.) Best Regards, The TopMarketGainers Team Don't Miss Our Next Huge Winner... Text 'GAINS' to '67076' to have our Trade Alerts Delivered Direct to your Cell Phone. (There is no charge. Msg&data rates may apply.) Follow Us On Twitter: DISCLAIMER This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website. We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future. MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated ten thousand dollars by ACN LLC. to conduct investor relations advertising and marketing for AGHI. We have been previously compensated ten thousand dollars by ACN LLC. to conduct investor relations advertising and marketing for AGHI on two seperate occassions -which have expired. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
ALong
by RedHotStocks
NAKD is back on high alert. Low-float, Nasdaq-listed company...===================== NAKD (Naked Brand Group Limited) Current Price: $0.3947 Float: 8.34M Investor Presentation Chart Analysis Website | Recent News ======================== Members, The up to +18% in realistic gains that today's trade idea delivered was the perfect way to start this shortened trading week. Now it's time to swing for the fences! Please turn your immediate attention to NAKD (Naked Brand Group Limited). Those of you that have been following us for awhile, know that NAKD has been one of our favorite/most profitable tickers of all-time. We first brought this Nasdaq-listed company to your attention back on 7/8/16 when it was trading at $1.37. Within 6-months shares had climbed over +168% from our alert price. NAKD then took its place as one of our largest long-term gainers of all-time, when it hit a high of $11.36 on June 20th, 2018. Since then, NAKD has been in a downtrend... But we have good news.... It appears that the bottom is finally in! After hitting an all-time low of $0.31 last Friday, shares of NAKD have held strong, and it looks like we may have an epic reversal in the making. NAKD closed today's session up nearly 3 percent, and as of right now shares of NAKD are up nearly five percent in after-hours trading! This after-hours action has us extremely bullish heading into tomorrow's trading session. One thing we've learned over time, is that NAKD is the kind of ticker that can go viral in minutes In fact, in just the past six months, we've witnessed shares of NAKD run-up over +40% on four separate occasions. Our current chart analysis shows the potential for a triple-digit move. With its low-float of just 8.34M, a nice boost in volume could send shares of NAKD soaring early, and if the Company releases any market friendly news.........Prepare for fireworks! We are anticipating another huge day for NAKD. This could be one of the biggest gainers on the Nasdaq tomorrow. As such, we are urging all members to read our full profile on NAKD, start their research, and to add it to the top of their watchlist! About Pressure Naked Brand Group Limited Naked Brand Group Limited (NAKD) is a leading intimate apparel and swimwear company with a diverse portfolio of brands. The company designs, manufactures and markets a portfolio of 11 company-owned and licensed brands, catering to a broad cross-section of consumers and market segments. Brands include Naked, Bendon, Bendon Man, Davenport, Fayreform, Hickory, Lovable, Pleasure State, Heidi Klum Intimates, Heidi Klum Man, Heidi Klum Swim. Naked Brand Group Limited products are available in 44 countries worldwide through 6,000 retail doors, a growing network of E-commerce sites and 61 company-owned Bendon retail and outlet stores in Australia and New Zealand. Brands are distributed through premier department stores, specialty stores, independent boutiques and third-party e-commerce sites globally, including Macy’s, Nordstrom, Saks Fifth Avenue, Harrods, Selfridges, Amazon and ASOS among others. For more information please visit www.nakedbrands.com. Investment Highlights Management believes the Company is positioned for accelerated growth in 2019! Scalable business model with a large, global revenue footprint Iconic brand and product portfolio, including an evergreen partnership with Heidi Klum Launched Heidi Klum Intimates Solutions line to over 4,000 CVS locations across the United States. Acquired several Tier 1 retail relationships including Bloomingdales, Nordstrom and Dilliards Closed merger transaction between Naked Brand Group and the internationally recognized Bendon Limited creates a unique retail operating platform capable of supporting USD$200m in revenue with minimal growth in G&A Completed acquisition of Fredericks of Hollywood Global E-Commerce Licensee, FOH Online Corp. In-store experience and store operations supplementing growing eCommerce sales Concurrent debt restructuring and equity financing fortifies balance sheet and enables the realization of new supply chain cost savings Public vehicle provides opportunity to leverage stock when opportunistic acquiring new brands There is a significant opportunity to consolidate a fragmented global marketplace which is expected to grow to USD $250B by 2022 Experienced management team with deep industry experience Recent Developments for NAKD Naked Brand Group Limited Reports First Half Fiscal 2019 Financial Results Key First Half Fiscal 2019 Financial Highlights: Net sales for the first half of 2019 decreased by 5.1% to NZD$56.8 million, or USD$38.6 million, compared to NZD$59.8 million, or USD$40.6 million, for the first half of 2018. Gross profit margin as a percentage of revenue decreased to 31.2% in the first half of 2019, as compared to approximately 32.7% in the first half of 2018. Operating expenses increased to NZD$43.7 million, or USD$29.7 million, in the first half of 2019, compared to NZD$38.8 million, or USD$26.4 million, in the first half of 2018. The increase in operating expenses was due to the costs incurred as part of the U.S. listing process NZD$5.1million or USD $3.5 million as well as non-cash impairment charges of NZD$4.1 million or USD$2.8 million. Net loss totaled NZD$26.5 million, or USD$18.07 million, in the first half of 2019, or (NZD$1.28), or (USD$0.87), per basic and diluted share, compared to a net loss of NZD$18.42 million, or USD$12.5 million, in the first half of 2018, or (NZD$0.89), or (USD$0.61), per basic and diluted share. Adjusted EBITDA loss totaled NZD$15.4million, or USD$10.5 million, in the first half of 2019 compared to the first half of 2018 of adjusted EBITDA loss of NZD$16.2million or USD$11.0million. Key First Half Fiscal 2019 and Subsequent Operational Highlights: Completed merger between Naked Brand Group Inc. and Bendon Limited creating a global leader in intimate apparel and swimwear. Completed debt restructuring and equity financing to fortify balance sheet and realize new supply chain cost savings. Appointed veteran apparel executives to accelerate rapidly growing e-commerce channel. Completed agreement with CVS Health and launched Heidi Klum Intimates Solutions line to over 4,000 CVS locations across the United States. Launched new Diffusion program nationwide with Costco Wholesale Australia. Launched retail and outlet store expansion strategy across Australia and New Zealand. Completed acquisition of Fredericks of Hollywood global e-commerce licensee, through the purchase of FOH Online Corp. Management Commentary “The first half fiscal 2019 was a very pivotal time for the newly combined company as we integrated both businesses, cleaned up our capital structure and eliminated some divisions in order to position Naked for the next phase of our e-commerce business,” said Justin Davis-Rice, CEO of Naked. “While today’s reported financial results reflect a period of transition, we believe the steps taken during this time will position the company for accelerated growth in the new year. We look forward to updating shareholders on these developments and new pending initiatives in early 2019 on our rescheduled conference call,” concluded Davis-Rice. First Half Fiscal 2019 Financial Results Net sales in the first half of 2019 totaled NZD$56.8 million, or USD$38.6 million, a decrease of 5.1% compared to NZD$59.8 million, or USD$40.6 million, in the first half of 2018. This decrease in net sales was primarily a result of vendor supply issues. Gross profit totaled approximately NZD$17.7 million, or USD$12.1 million, in the first half of 2019 as compared to NZD$19.6 million, or USD$13.3 million, in the first half of 2018. Gross profit margin as a percentage of revenue decreased to 31.2% in the first half of 2019, as compared to approximately 32.7% in the first half of 2018. The reduction in gross margin was caused by increased discounts provided to customers and sub-optimal stock mix due to the vendor supply issue. Operating expenses increased to NZD$43.7 million, or USD$29.7 million, in the first half of 2019, compared to NZD$38.8 million, or USD$26.4 million, in the first half of 2018. Net loss totaled NZD$26.5 million, or USD$18.07 million, in the first half of 2019, or (NZD$1.28), or (USD$0.87), per basic and diluted share, compared to a net loss of NZD$18.42 million, or USD$12.5 million, in the first half of 2018, or (NZD$0.89), or (USD$0.61), per basic and diluted share . The increase in net loss was due to reduced gross profit and increased expenses. Adjusted EBITDA loss decreased to NZD$15.4 million, or USD$10.5 million, in the first half of 2019 from NZD$16.3 million, or USD$11.1 million, in the first half of 2018. See below under the heading “Use of Non-GAAP Financial Information” for a discussion of EBITDA and a reconciliation of such measure to the most comparable measure calculated under U.S. generally accepted accounting principles ("GAAP"). Cash and cash equivalents at July 31, 2018 totaled NZD$4.2 million, or USD$2.9 million, as compared to $3.5 million, or USD$2.4 million, at July 31, 2017. Subsequent to the closing of the first half fiscal 2019, the company completed a USD$3.4 million private placement of ordinary shares and warrants with two accredited investors, including Naked CEO, Justin Davis-Rice. The New Zealand Dollar figures in this press release were converted to United States Dollar figures at an 0.68 exchange rate. Further details about the Company’s results in the first half 2019 are available on Form 6-K, which can be viewed by clicking here. Market Outlook: The global intimate wear market is expected to grow to $250 billion by 2022 The global underwear, hosiery and sports and swimwear market is expected to grow from $348b in 2017 to more than $416B in 2021 The average amount spent annually on Underwear, Hosiery and Sports and Swimwear is expected to grow 17% to $79.57 per capita in 2021 Consumers are not only purchasing more underwear (8 pieces per capita annually in 2017 compared to 6 in 2010), but they are spending more as well, with the average price per unit increasing 11% since 2010 Technical Analysis: We love these low-float, Nasdaq listed alerts, and NAKD has proven itself time and time again to be a significant winner for our members. Traders now have the opportunity to grab up shares of NAKD at its near all-time low. After hitting its all-time low of $0.31 last Friday, shares of NAKD have held strong, and it looks like we may have an epic reversal in the making. One thing we've learned over time, is that NAKD is the kind of ticker that can go viral in minutes In fact, in just the past six months, we've witnessed shares of NAKD run-up over +40% on four separate occasions. Our current chart analysis shows the potential for a triple-digit move. With its low-float of just 8.34M, a nice boost in volume could send shares of NAKD soaring early. Shares of NAKD were trading as high as $11.36 just under 8-months ago. A run back to those highs from today's alert price would show traders gains of over +2,778%! NAKD closed today's session up nearly 3 percent, and as of right now shares of NAKD are up nearly five percent in after-hours trading! This after-hours action has us extremely bullish heading into tomorrow's trading session. We are anticipating another huge day for NAKD. This could be one of the biggest gainers on the Nasdaq tomorrow. As such, we are urging all members to start their research on NAKD, and to add it to the top of their watchlist! Best Regards, The TopMarketGainers Team Don't Miss Our Next Huge Winner... Text 'GAINS' to '67076' to have our Trade Alerts Delivered Direct to your Cell Phone. (There is no charge. Msg&data rates may apply.) DISCLAIMER This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website. We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future. MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated ten thousand dollars by World Wide Holdings dba Invictus Resources to conduct investor relations advertising and marketing for NAKD. We have previously been compensated ten thousand dollars by World Wide Holdings dba Invictus Resources to conduct investor relations advertising and marketing for NAKD- which has expired. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
NLong
by RedHotStocks
1
$PBIO has a Perfect Chart w/ Millions in Revenue, Low Float &...$PBIO has a Perfect Chart w/ Millions in Revenue, Low Float & Insider Buying: ===================== PBIO (Pressure BioSciences Inc.) Current Price: $2.19 Float: 1.65M Chart Analysis Investor Presentation ======================== Members, We hope you enjoyed the up to +56% in intraday gains that today's trade idea provided. If you liked today's trade action, you are going to love what we have in store for you next. Please turn your immediate attention to PBIO (Pressure BioSciences Inc.). Just like our most recent winner, this leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry, trades on the OTCQB, and has tight float of less than 2M. PBIO traded nicely today, closing the session up nearly three percent. We feel confident that this bullish momentum will continue onto tomorrow, as it appears that an uptrend is beginning to take shape. PBIO has also been getting plenty of positive press as of late. The Company’s President and CEO, Mr. Richard T. Schumacher, recently joined Stock Day’s Mr. Everett Jolly to discuss the Company's recent successes. During the interview Mr. Schumacher discussed PBIO's most recent achievements, all of which could be considered bullish catalysts in the immediate future: Their recent collaboration With NutraFuels, Inc., The Commercial Launch of Their BioPharmaceuticals Contract Services Business. The Publication of More Than Twenty Scientific Papers on the Company’s Unique Pressure-Based Products During 2018. On top of this, we also noticed some insider buying from PBIO's management in late December. This leads us to believe that PBIO's management considers the Company's stock price to be undervalued at the moment. PBIO also looks like a clear cut winner from a technical standpoint as well. We've done our own chart analysis, and we have to admit, we haven't seen a chart this pretty in quite some time. This appears to be a bottom-chart play, sitting on a golden pocket, with the potential to more than double in price. It looks like we have another big mover on our hands here with PBIO. That being said, we are urging all members to read our full profile, start their research now, and consider grabbing up a position in PBIO tomorrow morning at 9:30AM EST! About Pressure BioSciences, Inc. Pressure BioSciences, Inc. (PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. Their products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or "PCT") hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Their primary focus is in the development of high pressure-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, food science, soil & plant biology, forensics, and counter-bioterror applications. Additionally, PBIO is actively expanding the use of their pressure-based technologies in the following areas: (1) the use of their recently acquired technology from BaroFold, Inc. (the "Barofold" technology) to allow entry into the biologics manufacturing and contract research services sector, and (2) the use of their recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology ("UST") platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. Investment Highlights Seasoned Management Team & Board of Directors Annual Revenue of $2.24M (FY2017) Three Novel, Enabling, Patent Protected, Proprietary Pressure-based Platforms Proven Core Technology (Over 300 PCT Systems Installed): Razor/Razorblade Business Model Sales into the Research Market (fast market penetration with minimal approvals required) Increasing Number of 3rd Party Publications from Marquee Laboratories PCT Breaks Through Bottlenecks and Barriers to Enable and Accelerate Scientific Discovery PreEMT Can Impact and Improve Protein Drug Therapeutics UST Offers the Potential to Produce Highly Stable Nanoemulsions, Including in the Food and CBD Markets Significant Multi-Billion Dollar Market Opportunity (~500K Scientists in 80K Labs Worldwide) Company Overview Three Business Segments - Three Unique Technology Platforms Research Products and Services (PCT Platform) PCT: Pressure Cycling Technology (alternating cycles of high/low pressure to control biomolecules) Focus: to improve the quality of biological sample preparation, one of the most crucial yet errorprone steps in all of scientific research, performed by tens of thousands of scientists worldwide in pharma, biotech, academia and government research laboratories. 15 Patents, 300 PCT Systems installed, 175+ customers, 120+ publications, 2017 revenue ($2.24M) Biological Contract Services (PreEMT Platform) PreEMT: Pressure Enabled Protein Manufacturing Technology Focus: to improve the quality of protein therapeutics, accelerate therapeutic protein development, and manufacture follow-on biologics by employing high pressure for disaggregation & controlled refolding of recombinant proteins into their native structures for desired drug activity. 8 Patents, Dec 2017 BaroFold Acquisition, Initial Contract Underway, Negotiating with Client #2 Nanoemulsion Manufacturing Services (UST Platform) UST: Ultra Shear Technology (combines high hydrostatic pressure & intense shear forces) Focus: to produce higher quality, more stable nanoemulsions with improved absorption, higher bioavailability, and lower surfactant levels: food, pharmaceuticals, nutraceuticals, cosmetics, lubricants, paint, and cannabis oil extracts (water soluble CBD) compared to standard emulsions Short-Term Growth Drivers Research Products & Services PCT Platform): New Next Generation Barocycler 2320EXTREME Additions to Sales & Marketing Team (one to four field sales managers in 2018) Novel Micro-Pestle Consumable…Potential Use in Pathology, etc. Four Additional PCT-based Instruments to be Released over Next 12 Months PBI Products Fill Existing Needs in $291B (2021 est.) Biopharmaceutical Market Biological Contract Services (PreEMT Platform): Consistent Revenue Stream fromServices to Protein Therapeutic Companies…plus the Potential for Millions of dollars from Royalties on Manufacturing Scale Licenses Nanoemulsion Manufacturing Services (UST Platform): Consistent Revenue Stream from Services to Food, Cosmetic, and Nutraceutical (CBD, CBG) Markets for Potential Development of Low Cost, Scalable Production of Nanoemulsions…plus the Potential for Millions of dollars from Royalties on Manufacturing Scale Licenses Recent Developments In late January PBIO announced news of a collaboration with NutraFuels Inc., to advance the development of a new generation of health and wellness nutraceutical products based on processing by PBI's proprietary Ultra Shear Technology (UST™) platform. The Companies believe that nanoemulsions prepared by the UST Platform will have improved quality and effectiveness compared to current emulsions, which will help to facilitate the development of a new generation of improved nutraceutical and other emulsion-based products, such as cosmetics. Edgar J. Ward, President and CEO of NTFU, said: "We pride ourselves in ensuring that we incorporate the highest level of quality possible in our manufactured products. When we heard that PBI was developing their new, proprietary UST processing platform, and learned of its potential to significantly increase the quality and effectiveness of nutraceutical products, we spoke with PBI and offered to help accelerate its commercial introduction. We are thrilled to be working with such experienced scientific leaders and innovators, in a program that we believe can change lives worldwide for the better." Mr. Ward continued: "We believe PBI's UST platform has the potential to create long-term room temperature stable, water-soluble nanoemulsions of oil-based solutions. Nanoemulsions are known to offer greater stability and bioavailability than the standard macroemulsions used today in nutraceuticals, cosmetics, and other industries. We are excited to have the opportunity to work with a life science industry leader in the optimization of a process that has the potential to bring higher quality not just to our products, but to nutraceutical products worldwide." Dr. Bradford A. Young, Chief Commercial Officer of PBI, commented: "We are pleased to have the opportunity to work with NTFU's scientists and manufacturing personnel in the development of new and improved nutraceutical products utilizing our UST platform. This proprietary technology employs ultra-high pressure and extreme shearing forces to create nano-scale emulsions of oil and water with long-term stability. For many oil-based products, the ability to create very small, nanometer-sized oil droplets that can effectively dissolve in water (nanoemulsions) can improve a product's appearance, sensory and medicinal benefits. There is a large and growing market opportunity for nutraceutical products with proven health and wellness benefits. We believe PBI's UST platform can help manufacturers accelerate growth and success in this market with higher quality, water-soluble, oil-based products with superior dietary absorption and shelf-life." Mr. Richard T. Schumacher, President and CEO of PBI, added: "We are excited to work with Edgar and his NTFU team in the optimization of our UST platform, which we believe will result in the development of new and beneficial health and wellness products. The staff at NTFU has years of experience in manufacturing nutraceutical products in a quality environment. They also have access to both raw materials and finished goods, both of which are needed for optimization. Finally, they have an existing analytical laboratory with state-of-the-art equipment and well-trained chemists who can perform testing on both pre and post-processed materials, which will be invaluable to the optimization process. This collaboration clearly supports both company's strategic objectives: we look forward to an exciting and mutually beneficial relationship with our colleagues at NutraFuels." Last month, PBIO announced the commercial launch of its Biopharmaceuticals Contract Services Business. The launch of this new business has been eagerly anticipated following the Company's acquisition of the assets of BaroFold, Inc. in December 2017, including patents, equipment, and other intellectual property relating to Barofold's unique, high pressure-based protein disaggregation and refolding platform. PBI expects that the unique Barofold technology platform will substantially improve the quality and costs of manufacturing protein therapeutics, by helping to resolve protein aggregation, improving solubility, and refolding complex misfolded protein therapeutic molecules into their desired, therapeutically-optimized conformations for improved drug efficacy and lower immunogenicity. Protein-based therapeutic drugs are a large and rapidly growing part of the global healthcare industry. There are over 200 therapeutic proteins and peptides approved for clinical use in the U.S. (THPdb database: crdd.osdd.net). Protein therapeutics are valued for their more potent and specific therapeutic effectiveness for many diseases, such as cancer and auto-immune disorders. They are also the preferred treatment choices for hormone and growth factor deficiencies. Research and Markets (May 2016) forecasted that the global protein drug market will grow to $248 billion by 2020. Market Outlook Proprietary Technology Platform Offers Improved Manufacturing for Protein Therapeutic Candidates and Positions PBIO to Service the $250 Billion Global Biopharmaceuticals Market The United States remains the largest medical device market in the world, with a market size of around $156 billion, and it represented about 40 percent of the global medical device market in 2017. U.S. exports of medical devices in key product categories identified by the Department of Commerce (DOC) exceeded $41 billion in that year. The medical technology industry (commonly referred to as medical devices) consists of articles, instruments, apparatuses, or machines that are used in the prevention, diagnosis or treatment of illness or disease, or for detecting, measuring, restoring, correcting, or modifying the structure or function of the body for some health purpose. Typically, the purpose of a medical device is not achieved by pharmacological, immunological, or metabolic means. The industry is responsible for almost 2 million jobs in the United States, including both direct and indirect employment. Medical technology directly accounts for well over 500,000 of these jobs. More than 80 percent of medical device companies in the United States consist of fewer than 50 employees, and many (notably start-up companies) have little or no sales revenue. The medical technology industry employs people in all 50 states. U.S. medical device companies are highly regarded globally for their innovative and high technology products. R&D spending continues to represent a high percentage of medical device industry expenditures, averaging 7 percent of revenue. Compared to several other industries including automotive, defense, and telecommunications, the medical device industry invests a higher percentage of yearly revenues into product innovation, reflecting the competitive nature of the industry and constant innovation and improvement of existing technologies. The medical device industry relies on several industries where the United States holds a competitive advantage, including microelectronics, telecommunications, instrumentation, biotechnology, and software development. Collaborations have led to recent advances including neuro-stimulators, stent technologies, biomarkers, robotic assistance, and implantable electronic devices. Since innovation fuels the medical device sector’s ongoing quest for better ways to treat and diagnose medical conditions, when coupled with patient life expectancy increasing and aging populations globally, the medical device sector should continue growing at a positive rate in the future. Technical Analysis AS we stated above, PBIO appears to be a clear cut winner from a technical standpoint as well. We've done our own chart analysis, and we have to admit, we haven't seen a chart this pretty in quite some time. This appears to be a bottom-chart play, sitting on a golden pocket, with the potential to more than double in price. PBIO has plenty of room to run from here. The Company is currently down fifty-six percent from its 52-week high of $5.00. A run back to that high would show traders over +128% in pure profit from today's alert price. Let's also not forget that the float for PBIO is ridiculously thin at just 1.65M. With a float that tight, PBIO has the potential to break out for significant gains should it see a sudden burst in trade volume. If any market friendly news were to be released, we could see shares of PBIO sky-rocket! We are urging all members to start their research now, and consider grabbing up a position in PBIO tomorrow morning at 9:30AM EST! (*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.) Best Regards, The TopMarketGainers Team Don't Miss Our Next Huge Winner... Text 'GAINS' to '67076' to have our Trade Alerts Delivered Direct to your Cell Phone. (There is no charge. Msg&data rates may apply.) DISCLAIMER This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website. We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future. MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated ten thousand dollars by the Financial Marketing Group to conduct investor relations advertising and marketing for PBIO. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
OTC:PBIOLong
by RedHotStocks
$SALT Will Make You FILTHY RICH In The Next Altseason! Why?Due to BTC Price ranging right now back and forth, somehow, whale or somebody accumulating them hardly, preparing for the very next altseason coming with a bag full of crypto and ready to dump it all. Even tho there are many salty people on the current market, just look at SALT chart. It's a sweet entry and very low risk R:R right now. With only 120 mills total supply and listed on Huobi, OKEx, Bittrex, Upbit and Binance, man you know the potential are going to get crazy for this one. Don't miss it. Trade safe!
SLong
by blockchaindedi
5